Status:
UNKNOWN
Impact of Topical Antiadhesion Therapy on Wound Healing and Postoperative Pain After Anal Surgery
Lead Sponsor:
Mansoura University
Conditions:
Anal Wound
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
2QR-complex is a patented molecule extracted from Aloe vera barbadensis leaves that blocks the adhesion of pathogenic microbes to human epithelial cells and tissues \[9\]. Anti-adhesion therapy such a...
Eligibility Criteria
Inclusion
- Adult patients of either sex with simple anal fistula, chronic anal fissure, or grade III/IV hemorrhoids will be included.
Exclusion
- Patients with other anal conditions, diabetic patients, patients under steroid or immunosuppressive therapy will be excluded.
Key Trial Info
Start Date :
February 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04275596
Start Date
February 10 2020
End Date
May 30 2021
Last Update
February 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516